Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05798676

Maternal Characteristics Associated With Child Growth and Adiposity

The goal of this observational study is to investigate the concentrations of leptin, insulin, liver expressed antimicrobial peptide 2 (LEAP2), and cortisol in plasma and breast milk and their relationship with eating behavior, growth, adiposity and with the levels of these hormones in infants, comparing mothers with normal weight and with pre-pregnancy overweight/obesity. The main question[s] it aims to answer are:

* Are maternal hormones associated with child growth and adiposity * Are maternal hormone receptors associated with child growth and adiposity * Are infant hormones and their receptors associated with child growth and adiposity * Are maternal and infant hormones and their receptors associated with child eating behavior Participants will provide milk and blood samples. Researchers will compare mothers with normal weight and with pre-pregnancy overweight/obesity to see if there are differences in child growth and adiposity .

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lactating women with pre-pregnancy normal weight and overweight or obesity as described by the World Health Organization.

Exclusion criteria

  • Diabetes (Type I or II or gestational)
  • Multiple pregnancy
  • Hypertensive disorders during pregnancy
  • Delivery of pre-term infant (<37 weeks).

Treatment and study plan

overweight/obesity

Other

the consequences of maternal pregestational overweight/obesity on infant´s growth and adiposity will be studied

Primary outcomes

  1. infant weight

    Time frame: from birth to 2 years old

    weight in kilograms

  2. infant height

    Time frame: from birth to 2 years old

    height in centimeters

  3. infant body mass index (BMI)

    Time frame: from birth to 2 years old

    weight and height will be combined to report BMI in kg/m^2

  4. infant upper arm circumference

    Time frame: from birth to 2 years old

    upper arm circumference in centimeters

  5. infant skinfold thickness

    Time frame: from birth to 2 years old

    skinfold thickness in centimeters

  6. infant blood leptin concentration

    Time frame: six months old

    blood leptin concentration (ng/ml)

  7. infant blood cortisol concentration

    Time frame: six months old

    blood cortisol concentration (ug%)

  8. infant saliva cortisol concentration

    Time frame: six months old

    saliva cortisol (ug%)

  9. infant blood insulin concentration

    Time frame: six months old

    blood insulin concentration (uU/ml)

  10. infant insulin receptor gene expression in peripheral blood mononuclear cells

    Time frame: six months old

    insulin receptor gene expression in peripheral blood mononuclear cells (relative expression)

  11. infant leptin receptor gene expression in peripheral blood mononuclear cells

    Time frame: six months old

    leptin receptor gene expression in peripheral blood mononuclear cells (relative expression)

  12. infant glucocorticoid receptor gene expression in peripheral blood mononuclear cells

    Time frame: six months old

    glucocorticoid receptor gene expression in peripheral blood mononuclear cells (relative expression)

  13. infant blood LEAP2 concentration

    Time frame: six months old

    blood LEAP2 concentration (pg/ml)

  14. infant eating behavior assessed in a Taste acceptance test

    Time frame: at 18 month od

    Outcome Measures Infant taste acceptance was assessed using two complementary measures: an Ingestion Ratio (IR) and a Liking Ratio (LR). Sweet and fat taste acceptance were evaluated using a lactose solution (0.2 M) and a fat emulsion (3.5% w/v), respectively, with water used as a reference. During each test, infants were sequentially offered bottles containing water and the tastant. Intake volume was determined by weighing bottles before and after ingestion.

    The IR was calculated as the volume of tastant consumed divided by the total volume of tastant plus water consumed, allowing comparison across infants by accounting for individual differences in sucking behavior.

    The LR was based on a blinded experimenter's assessment of the infant's overall behavioral response using a standardized 5-point scale ranging from strong rejection to strong acceptance. Both ratios ranged from 0 to 1, with 0.5 indicating indifference relative to water.

Secondary outcomes

  1. maternal blood leptin concentration

    Time frame: 15 days, three and six months postpartum

    blood leptin concentration (ng/ml)

  2. maternal milk leptin concentration

    Time frame: 15 days, three and six months postpartum

    milk leptin concentration (ng/ml)

  3. maternal blood insulin concentration

    Time frame: 15 days, three and six months postpartum

    blood insulin concentration (uU/ml)

  4. maternal milk insulin concentration

    Time frame: 15 days, three and six months postpartum

    milk insulin concentration (uU/ml)

  5. maternal blood cortisol concentration

    Time frame: 15 days, three and six months postpartum

    blood cortisol concentration (ug%)

  6. maternal milk cortisol concentration

    Time frame: 15 days, three and six months postpartum

    milk cortisol concentration (ug%)

  7. maternal insulin receptor gene expression in peripheral blood mononuclear cells

    Time frame: 15 days, three and six months postpartum

    insulin receptor gene expression in peripheral blood mononuclear cells (relative expression)

  8. maternal leptin receptor gene expression in peripheral blood mononuclear cells

    Time frame: 15 days, three and six months postpartum

    leptin receptor gene expression in peripheral blood mononuclear cells (relative expression)

  9. maternal glucocorticoid receptor gene expression in peripheral blood mononuclear cells

    Time frame: 15 days, three and six months postpartum

    glucocorticoid receptor gene expression in peripheral blood mononuclear cells (relative expression)

  10. maternal blood LEAP2 concentration

    Time frame: 15 days, three and six months postpartum

    blood LEAP2 concentration (pg/ml)

  11. maternal milk LEAP2 concentration

    Time frame: 15 days, three and six months postpartum

    milk LEAP2 concentration (pg/ml)

Study contacts

Contact information is provided by the study sponsor or research team.

Maria F Andreoli, PhD

CONTACT

[email protected]

54 221 4535901 ext. 1767

Sponsors and collaborators

Lead sponsor

Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Other

Registry information

Official study title

Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood

Important dates

Study start
2019
Primary completion
2028
Study completion
2028
First posted
Apr 4, 2023
Registry last updated
Dec 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.